{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:35:33Z","timestamp":1794317733941,"version":"4.9.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG077484"],"award-info":[{"award-number":["RF1AG077484"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U24AG072458"],"award-info":[{"award-number":["U24AG072458"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG077253"],"award-info":[{"award-number":["R01AG077253"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07499-w","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:15:16Z","timestamp":1736885716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities"],"prefix":"10.1038","volume":"8","author":[{"given":"Filippa","family":"Lo Cascio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhyeorn","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmi","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1138-237X","authenticated-orcid":false,"given":"Nicha","family":"Puangmalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5017-7312","authenticated-orcid":false,"given":"Nemil","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Shchankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0225-9855","authenticated-orcid":false,"given":"Cankun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-7075","authenticated-orcid":false,"given":"Hongjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-8392","authenticated-orcid":false,"given":"Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0456-452X","authenticated-orcid":false,"given":"Mauro","family":"Montalbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6216-8640","authenticated-orcid":false,"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"7499_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/B978-0-12-802395-2.00025-0","volume":"145","author":"GG Kovacs","year":"2017","unstructured":"Kovacs, G. G. Tauopathies. Handb. Clin. Neurol. 145, 355\u2013368 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"7499_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt, T., Stieler, J. T. & Holzer, M. Tau and tauopathies. Brain Res. Bull. 126, 238\u2013292 (2016).","journal-title":"Brain Res. Bull."},{"key":"7499_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters, C. L. et al. Alzheimer\u2019s disease. Nat. Rev. Dis. Primer 1, 15056 (2015).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"7499_CR4","doi-asserted-by":"publisher","unstructured":"Sengupta, U. & Kayed, R. Tau oligomers as pathogenic seeds: preparation, characterization, and propagation in vitro and in vivo. in Tau Protein: Methods and Protocols (ed. Smet-Nocca, C.) 147\u2013183 https:\/\/doi.org\/10.1007\/978-1-0716-3629-9_9 (Springer, 2024).","DOI":"10.1007\/978-1-0716-3629-9_9"},{"key":"7499_CR5","doi-asserted-by":"publisher","first-page":"1922.e7","DOI":"10.1016\/j.neurobiolaging.2013.01.017","volume":"34","author":"E Majounie","year":"2013","unstructured":"Majounie, E. et al. Variation in tau isoform expression in different brain regions and disease states. Neurobiol. Aging 34, 1922.e7\u20131922.e12 (2013).","journal-title":"Neurobiol. Aging"},{"key":"7499_CR6","doi-asserted-by":"publisher","first-page":"707268","DOI":"10.3389\/fcell.2021.707268","volume":"9","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Cao, Y., Ma, L., Wei, Y. & Li, H. Possible mechanisms of Tau spread and toxicity in Alzheimer\u2019s disease. Front. Cell Dev. Biol. 9, 707268 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"7499_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2503-3","volume":"11","author":"N Puangmalai","year":"2020","unstructured":"Puangmalai, N. et al. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer\u2019s disease, progressive supranuclear palsy and dementia with Lewy bodies. Cell Death Dis 11, 314 (2020).","journal-title":"Cell Death Dis"},{"key":"7499_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/2051-5960-2-73","volume":"2","author":"JE Gerson","year":"2014","unstructured":"Gerson, J. E. et al. Characterization of tau oligomeric seeds in progressive supranuclear palsy. Acta Neuropathol. Commun. 2, 73 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"7499_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13112","volume":"33","author":"M Montalbano","year":"2023","unstructured":"Montalbano, M., Majmundar, L., Sengupta, U., Fung, L. & Kayed, R. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer\u2019s disease, progressive supranuclear palsy, and dementia with Lewy bodies. Brain Pathol. Zurich Switz. 33, e13112 (2023).","journal-title":"Brain Pathol. Zurich Switz."},{"key":"7499_CR10","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton, L. K., Blurton-Jones, M., Myczek, K., Trojanowski, J. Q. & LaFerla, F. M. Synergistic interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J. Neurosci. 30, 7281\u20137289 (2010).","journal-title":"J. Neurosci."},{"key":"7499_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/00048674231177219","volume":"58","author":"KS Chin","year":"2024","unstructured":"Chin, K. S. et al. Tau in dementia with Lewy bodies. Aust. N. Z. J. Psychiatry 58, 175\u2013182 (2024).","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"7499_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","volume":"80","author":"KS Chin","year":"2020","unstructured":"Chin, K. S., Yassi, N., Churilov, L., Masters, C. L. & Watson, R. Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis. Parkinsonism Relat. Disord. 80, 184\u2013193 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"7499_CR13","doi-asserted-by":"publisher","first-page":"eadn7655","DOI":"10.1126\/sciadv.adn7655","volume":"10","author":"CX Yap","year":"2024","unstructured":"Yap, C. X. et al. Brain cell-type shifts in Alzheimer\u2019s disease, autism, and schizophrenia interrogated using methylomics and genetics. Sci. Adv. 10, eadn7655 (2024).","journal-title":"Sci. Adv."},{"key":"7499_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tins.2022.11.006","volume":"46","author":"KM Igarashi","year":"2023","unstructured":"Igarashi, K. M. Entorhinal cortex dysfunction in Alzheimer\u2019s disease. Trends Neurosci. 46, 124\u2013136 (2023).","journal-title":"Trends Neurosci."},{"key":"7499_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt274","volume":"6","author":"PC Donaghy","year":"2014","unstructured":"Donaghy, P. C. & McKeith, I. G. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res. Ther. 6, 46 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"7499_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2009.05.019","volume":"32","author":"R Frigerio","year":"2011","unstructured":"Frigerio, R. et al. Incidental lewy body disease: do some cases represent a preclinical stage of Dementia with Lewy Bodies? Neurobiol. Aging 32, 857\u2013863 (2011).","journal-title":"Neurobiol. Aging"},{"key":"7499_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday, G. M., Song, Y. J. C. & Harding, A. J. Striatal \u03b2-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J. Neural Transm. 118, 713\u2013719 (2011).","journal-title":"J. Neural Transm."},{"key":"7499_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger, K. A. & Attems, J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol. 112, 253\u2013260 (2006).","journal-title":"Acta Neuropathol."},{"key":"7499_CR19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271\u20131288 (2014).","journal-title":"Neuron"},{"key":"7499_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman, S. K. et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92, 796\u2013812 (2016).","journal-title":"Neuron"},{"key":"7499_CR21","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc. Natl Acad. Sci. USA 111, E4376\u2013E4385 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7499_CR22","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1074\/jbc.M117.815357","volume":"293","author":"KH Strang","year":"2018","unstructured":"Strang, K. H. et al. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies. J. Biol. Chem. 293, 2408\u20132421 (2018).","journal-title":"J. Biol. Chem."},{"key":"7499_CR23","doi-asserted-by":"publisher","unstructured":"Parra Bravo, C., Naguib, S. A. & Gan, L. Cellular and pathological functions of tau. Nat. Rev. Mol. Cell Biol. 1\u201320 https:\/\/doi.org\/10.1038\/s41580-024-00753-9 (2024).","DOI":"10.1038\/s41580-024-00753-9"},{"key":"7499_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sbi.2020.05.011","volume":"64","author":"SH Scheres","year":"2020","unstructured":"Scheres, S. H., Zhang, W., Falcon, B. & Goedert, M. Cryo-EM structures of tau filaments. Curr. Opin. Struct. Biol. 64, 17\u201325 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"7499_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"7499_CR26","doi-asserted-by":"publisher","first-page":"eabg0253","DOI":"10.1126\/scitranslmed.abg0253","volume":"14","author":"C Kim","year":"2022","unstructured":"Kim, C. et al. Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer\u2019s disease. Sci. Transl. Med. 14, eabg0253 (2022).","journal-title":"Sci. Transl. Med."},{"key":"7499_CR27","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3390\/cells11192997","volume":"11","author":"L Hromadkova","year":"2022","unstructured":"Hromadkova, L., Siddiqi, M. K., Liu, H. & Safar, J. G. Populations of Tau conformers drive prion-like strain effects in Alzheimer\u2019s disease and related dementias. Cells 11, 2997 (2022).","journal-title":"Cells"},{"key":"7499_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nbd.2017.03.014","volume":"109","author":"C Condello","year":"2018","unstructured":"Condello, C. & St\u00f6ehr, J. A\u03b2 propagation and strains: Implications for the phenotypic diversity in Alzheimer\u2019s disease. Neurobiol. Dis. 109, 191\u2013200 (2018).","journal-title":"Neurobiol. Dis."},{"key":"7499_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359\u2013363 (2021).","journal-title":"Nature"},{"key":"7499_CR30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature03680","volume":"435","author":"R Nelson","year":"2005","unstructured":"Nelson, R. et al. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435, 773\u2013778 (2005).","journal-title":"Nature"},{"key":"7499_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420\u2013423 (2019).","journal-title":"Nature"},{"key":"7499_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser, M. et al. Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585, 464\u2013469 (2020).","journal-title":"Nature"},{"key":"7499_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep00700","volume":"2","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves, C. A. et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci. Rep. 2, 700 (2012).","journal-title":"Sci. Rep."},{"key":"7499_CR34","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1471-4159.2009.06511.x","volume":"112","author":"MA Meraz-R\u00edos","year":"2010","unstructured":"Meraz-R\u00edos, M. A., Lira-De Le\u00f3n, K. I., Campos-Pe\u00f1a, V., De Anda-Hern\u00e1ndez, M. A. & Mena-L\u00f3pez, R. Tau oligomers and aggregation in Alzheimer\u2019s disease. J. Neurochem. 112, 1353\u20131367 (2010).","journal-title":"J. Neurochem."},{"key":"7499_CR35","doi-asserted-by":"publisher","first-page":"fcz004","DOI":"10.1093\/braincomms\/fcz004","volume":"1","author":"A Bittar","year":"2019","unstructured":"Bittar, A. et al. Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury. Brain Commun 1, fcz004 (2019).","journal-title":"Brain Commun"},{"key":"7499_CR36","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves, C. A. et al. Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease. FASEB J. 26, 1946\u20131959 (2012).","journal-title":"FASEB J."},{"key":"7499_CR37","doi-asserted-by":"publisher","first-page":"101766","DOI":"10.1016\/j.jbc.2022.101766","volume":"298","author":"N Puangmalai","year":"2022","unstructured":"Puangmalai, N. et al. Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer\u2019s disease. J. Biol. Chem. 298, 101766 (2022).","journal-title":"J. Biol. Chem."},{"key":"7499_CR38","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/pro.3499","volume":"27","author":"G Ghag","year":"2018","unstructured":"Ghag, G. et al. Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior. Protein Sci. 27, 1901\u20131909 (2018).","journal-title":"Protein Sci."},{"key":"7499_CR39","doi-asserted-by":"publisher","first-page":"E782","DOI":"10.1073\/pnas.1714966115","volume":"115","author":"C Condello","year":"2018","unstructured":"Condello, C. et al. Structural heterogeneity and intersubject variability of A\u03b2 in familial and sporadic Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 115, E782\u2013E791 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7499_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2300769120","volume":"120","author":"H Yang","year":"2023","unstructured":"Yang, H. et al. EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains. Proc. Natl Acad. Sci. USA 120, e2300769120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7499_CR41","doi-asserted-by":"publisher","first-page":"14807","DOI":"10.1074\/jbc.RA120.014630","volume":"295","author":"F Lo Cascio","year":"2020","unstructured":"Lo Cascio, F. et al. Modulating disease-relevant tau oligomeric strains by small molecules. J. Biol. Chem. 295, 14807\u201314825 (2020).","journal-title":"J. Biol. Chem."},{"key":"7499_CR42","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1073\/pnas.0409079102","volume":"102","author":"G Legname","year":"2005","unstructured":"Legname, G. et al. Strain-specified characteristics of mouse synthetic prions. Proc. Natl Acad. Sci. USA 102, 2168\u20132173 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7499_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jmb.2011.07.021","volume":"413","author":"S Ghaemmaghami","year":"2011","unstructured":"Ghaemmaghami, S. et al. Conformational transformation and selection of synthetic prion strains. J. Mol. Biol. 413, 527\u2013542 (2011).","journal-title":"J. Mol. Biol."},{"key":"7499_CR44","doi-asserted-by":"publisher","first-page":"34389","DOI":"10.1074\/jbc.M114.611368","volume":"289","author":"K Tepper","year":"2014","unstructured":"Tepper, K. et al. Oligomer formation of tau protein hyperphosphorylated in cells. J. Biol. Chem. 289, 34389\u201334407 (2014).","journal-title":"J. Biol. Chem."},{"key":"7499_CR45","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s12035-023-03211-3","volume":"60","author":"K Moore","year":"2023","unstructured":"Moore, K., Sengupta, U., Puangmalai, N., Bhatt, N. & Kayed, R. Polymorphic Alpha-Synuclein Oligomers: characterization and differential detection with novel corresponding antibodies. Mol. Neurobiol. 60, 2691\u20132705 (2023).","journal-title":"Mol. Neurobiol."},{"key":"7499_CR46","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s12035-020-01913-6","volume":"57","author":"U Sengupta","year":"2020","unstructured":"Sengupta, U. et al. Polymorphic \u03b1-Synuclein strains modified by dopamine and docosahexaenoic acid interact differentially with tau protein. Mol. Neurobiol. 57, 2741\u20132765 (2020).","journal-title":"Mol. Neurobiol."},{"key":"7499_CR47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbadis.2014.12.018","volume":"1852","author":"BW Baron","year":"2015","unstructured":"Baron, B. W., Baron, R. M. & Baron, J. M. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases. Biochim. Biophys. Acta BBA - Mol. Basis Dis. 1852, 742\u2013748 (2015).","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"7499_CR48","doi-asserted-by":"publisher","first-page":"e98858","DOI":"10.15252\/embj.201798858","volume":"37","author":"T M\u00fcller","year":"2018","unstructured":"M\u00fcller, T. et al. Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons. EMBO J. 37, e98858 (2018).","journal-title":"EMBO J."},{"key":"7499_CR49","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41436-021-01114-z","volume":"23","author":"HK Harris","year":"2021","unstructured":"Harris, H. K. et al. Disruption of RFX family transcription factors causes autism, attention-deficit\/hyperactivity disorder, intellectual disability, and dysregulated behavior. Genet. Med. 23, 1028\u20131040 (2021).","journal-title":"Genet. Med."},{"key":"7499_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27601-0","volume":"13","author":"B Sanders","year":"2022","unstructured":"Sanders, B. et al. Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants. Nat. Commun. 13, 27 (2022).","journal-title":"Nat. Commun."},{"key":"7499_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-020-00324-7","volume":"11","author":"T Yoo","year":"2020","unstructured":"Yoo, T. et al. A DLG2 deficiency in mice leads to reduced sociability and increased repetitive behavior accompanied by aberrant synaptic transmission in the dorsal striatum. Mol. Autism 11, 19 (2020).","journal-title":"Mol. Autism"},{"key":"7499_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40263-018-0593-6","volume":"33","author":"AF Batista","year":"2019","unstructured":"Batista, A. F., Bodart-Santos, V., De Felice, F. G. & Ferreira, S. T. Neuroprotective actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer\u2019s and Parkinson\u2019s Diseases. CNS Drugs 33, 209\u2013223 (2019).","journal-title":"CNS Drugs"},{"key":"7499_CR53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/bpa.12044","volume":"23","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera, F. et al. \u2018Prion-like\u2019 templated misfolding in tauopathies. Brain Pathol. Zurich Switz. 23, 342\u2013349 (2013).","journal-title":"Brain Pathol. Zurich Switz."},{"key":"7499_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-015-0254-7","volume":"3","author":"ME Bernis","year":"2015","unstructured":"Bernis, M. E. et al. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol. Commun. 3, 75 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"7499_CR55","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner, S. B. et al. Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl Acad. Sci. USA 112, E5308\u2013E5317 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7499_CR56","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00401-022-02476-7","volume":"144","author":"SAM Holec","year":"2022","unstructured":"Holec, S. A. M. et al. Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human \u03b1-synuclein. Acta Neuropathol. 144, 677\u2013690 (2022).","journal-title":"Acta Neuropathol."},{"key":"7499_CR57","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.3233\/JAD-132477","volume":"40","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza, D. L. et al. Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. J. Alzheimers Dis. 40, S97\u2013S111 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"7499_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","volume":"5","author":"A Mudher","year":"2017","unstructured":"Mudher, A. et al. What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol. Commun. 5, 99 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"7499_CR59","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.bpj.2012.09.032","volume":"103","author":"A Nath","year":"2012","unstructured":"Nath, A. et al. The conformational ensembles of \u03b1-synuclein and tau: combining single-molecule FRET and simulations. Biophys. J. 103, 1940\u20131949 (2012).","journal-title":"Biophys. J."},{"key":"7499_CR60","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.76494","volume":"11","author":"S L\u00f6vestam","year":"2022","unstructured":"L\u00f6vestam, S. et al. Assembly of recombinant tau into filaments identical to those of Alzheimer\u2019s disease and chronic traumatic encephalopathy. eLife 11, e76494 (2022).","journal-title":"eLife"},{"key":"7499_CR61","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/2211-5463.13657","volume":"13","author":"A Tarutani","year":"2023","unstructured":"Tarutani, A. et al. Cryo-EM structures of tau filaments from SH-SY5Y cells seeded with brain extracts from cases of Alzheimer\u2019s disease and corticobasal degeneration. FEBS Open Bio 13, 1394\u20131404 (2023).","journal-title":"FEBS Open Bio"},{"key":"7499_CR62","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/10409238.2016.1226251","volume":"51","author":"JE Gerson","year":"2016","unstructured":"Gerson, J. E., Mudher, A. & Kayed, R. Potential mechanisms and implications for the formation of tau oligomeric strains. Crit. Rev. Biochem. Mol. Biol. 51, 482\u2013496 (2016).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"7499_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4939-7816-8_9","volume":"1779","author":"U Sengupta","year":"2018","unstructured":"Sengupta, U., Carretero-Murillo, M. & Kayed, R. Preparation and characterization of Tau Oligomer Strains. Methods Mol. Biol. 1779, 113\u2013146 (2018).","journal-title":"Methods Mol. Biol."},{"key":"7499_CR64","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.biopsych.2017.12.018","volume":"84","author":"DL Castillo-Carranza","year":"2018","unstructured":"Castillo-Carranza, D. L., Guerrero-Mu\u00f1oz, M. J., Sengupta, U., Gerson, J. E. & Kayed, R. \u03b1-Synuclein Oligomers Induce a Unique Toxic Tau Strain. Biol. Psychiatry 84, 499\u2013508 (2018).","journal-title":"Biol. Psychiatry"},{"key":"7499_CR65","doi-asserted-by":"publisher","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","volume":"286","author":"KR Patterson","year":"2011","unstructured":"Patterson, K. R. et al. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J. Biol. Chem. 286, 23063\u201323076 (2011).","journal-title":"J. Biol. Chem."},{"key":"7499_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. The release and trans-synaptic transmission of Tau via exosomes. Mol. Neurodegener. 12, 5 (2017).","journal-title":"Mol. Neurodegener."},{"key":"7499_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9490","volume":"6","author":"S Takeda","year":"2015","unstructured":"Takeda, S. et al. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer\u2019s disease brain. Nat. Commun. 6, 8490 (2015).","journal-title":"Nat. Commun."},{"key":"7499_CR68","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","volume":"78","author":"U Sengupta","year":"2015","unstructured":"Sengupta, U. et al. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. Biol. Psychiatry 78, 672\u2013683 (2015).","journal-title":"Biol. Psychiatry"},{"key":"7499_CR69","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1742-4658.2005.04571.x","volume":"272","author":"P Zabrocki","year":"2005","unstructured":"Zabrocki, P. et al. Characterization of \u03b1-synuclein aggregation and synergistic toxicity with protein tau in yeast. FEBS J. 272, 1386\u20131400 (2005).","journal-title":"FEBS J."},{"key":"7499_CR70","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm.4011","volume":"22","author":"N Myeku","year":"2016","unstructured":"Myeku, N. et al. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat. Med. 22, 46\u201353 (2016).","journal-title":"Nat. Med."},{"key":"7499_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep09964","volume":"5","author":"A Elie","year":"2015","unstructured":"Elie, A. et al. Tau co-organizes dynamic microtubule and actin networks. Sci. Rep. 5, 9964 (2015).","journal-title":"Sci. Rep."},{"key":"7499_CR72","doi-asserted-by":"publisher","first-page":"740550","DOI":"10.3389\/fcell.2021.740550","volume":"9","author":"T Rico","year":"2021","unstructured":"Rico, T. et al. Tau stabilizes chromatin compaction. Front. Cell Dev. Biol. 9, 740550 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"7499_CR73","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1038\/tp.2016.296","volume":"7","author":"E Lauretti","year":"2017","unstructured":"Lauretti, E., Li, J.-G., Di Meco, A. & Pratic\u00f2, D. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model. Transl. Psychiatry 7, e1020\u2013e1020 (2017).","journal-title":"Transl. Psychiatry"},{"key":"7499_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/srep33047","volume":"6","author":"Z Mansuroglu","year":"2016","unstructured":"Mansuroglu, Z. et al. Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin. Sci. Rep. 6, 33047 (2016).","journal-title":"Sci. Rep."},{"key":"7499_CR75","doi-asserted-by":"publisher","first-page":"742790","DOI":"10.3389\/fnmol.2021.742790","volume":"14","author":"M Montalbano","year":"2021","unstructured":"Montalbano, M. et al. Tau Modulates mRNA transcription, alternative polyadenylation profiles of hnRNPs, chromatin remodeling and spliceosome complexes. Front. Mol. Neurosci. 14, 742790 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"7499_CR76","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1073\/pnas.0401911101","volume":"101","author":"M Margittai","year":"2004","unstructured":"Margittai, M. & Langen, R. Template-assisted filament growth by parallel stacking of tau. Proc. Natl Acad. Sci. USA 101, 10278\u201310283 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7499_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55419-w","volume":"9","author":"F Lo Cascio","year":"2019","unstructured":"Lo Cascio, F. et al. Toxic Tau Oligomers modulated by novel curcumin derivatives. Sci. Rep. 9, 19011 (2019).","journal-title":"Sci. Rep."},{"key":"7499_CR78","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"7499_CR79","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1021\/bi1016233","volume":"49","author":"CA Lasagna-Reeves","year":"2010","unstructured":"Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Guerrero-Muoz, M. J., Jackson, G. R. & Kayed, R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49, 10039\u201310041 (2010).","journal-title":"Biochemistry"},{"key":"7499_CR80","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/prot.23188","volume":"80","author":"C Louis-Jeune","year":"2012","unstructured":"Louis-Jeune, C., Andrade-Navarro, M. A. & Perez-Iratxeta, C. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Proteins 80, 374\u2013381 (2012).","journal-title":"Proteins"},{"key":"7499_CR81","doi-asserted-by":"publisher","first-page":"863141","DOI":"10.3389\/fmolb.2022.863141","volume":"9","author":"A Micsonai","year":"2022","unstructured":"Micsonai, A. et al. Disordered\u2013ordered protein binary classification by circular dichroism spectroscopy. Front. Mol. Biosci. 9, 863141 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"7499_CR82","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-020-01012-6","volume":"8","author":"KM Farmer","year":"2020","unstructured":"Farmer, K. M. et al. P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer\u2019s disease. Acta Neuropathol. Commun. 8, 132 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"7499_CR83","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2020.01.027","volume":"180","author":"T Arakhamia","year":"2020","unstructured":"Arakhamia, T. et al. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell 180, 633\u2013644.e12 (2020).","journal-title":"Cell"},{"key":"7499_CR84","doi-asserted-by":"publisher","first-page":"105130","DOI":"10.1016\/j.nbd.2020.105130","volume":"146","author":"M Montalbano","year":"2020","unstructured":"Montalbano, M. et al. TDP-43 and Tau Oligomers in Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and frontotemporal dementia. Neurobiol. Dis. 146, 105130 (2020).","journal-title":"Neurobiol. Dis."},{"key":"7499_CR85","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1021\/acs.jproteome.7b00432","volume":"16","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Sun, H., Zhang, J., Brasier, A. R. & Zhao, Y. Quantitative assessment of the effects of trypsin digestion methods on affinity purification-mass spectrometry-based protein-protein interaction analysis. J. Proteome Res. 16, 3068\u20133082 (2017).","journal-title":"J. Proteome Res."},{"key":"7499_CR86","doi-asserted-by":"crossref","unstructured":"Tubaon, R. M., Haddad, P. R. & Quirino, J. P. Sample clean-up strategies for ESI mass spectrometry applications in bottom-up proteomics: trends from 2012 to 2016. Proteomics 17, 1700011 (2017).","DOI":"10.1002\/pmic.201700011"},{"key":"7499_CR87","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"7499_CR88","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics MCP 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell. Proteomics MCP"},{"key":"7499_CR89","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"7499_CR90","doi-asserted-by":"publisher","first-page":"eadj5958","DOI":"10.1126\/scitranslmed.adj5958","volume":"16","author":"S Gaikwad","year":"2024","unstructured":"Gaikwad, S. et al. Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice. Sci. Transl. Med. 16, eadj5958 (2024).","journal-title":"Sci. Transl. Med."},{"key":"7499_CR91","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"7499_CR92","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"7499_CR93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\u201344 (2019).","journal-title":"Nat. Biotechnol."},{"key":"7499_CR94","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"7499_CR95","doi-asserted-by":"publisher","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"The Gene Ontology Consortium","year":"2023","unstructured":"Gene Ontology Consortium, The et al. The Gene Ontology knowledgebase in 2023. Genetics 224, iyad031 (2023).","journal-title":"Genetics"},{"key":"7499_CR96","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07499-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07499-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07499-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:57:24Z","timestamp":1736888244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07499-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7499"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07499-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}